Paller CJ - Search Results

1

Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.

Nakazawa M, Lu C, Chen Y, Paller CJ, Carducci MA, Eisenberger MA, Luo J, Antonarakis ES. Nakazawa M, et al. Among authors: paller cj. Ann Oncol. 2015 Sep;26(9):1859-1865. doi: 10.1093/annonc/mdv282. Epub 2015 Jun 27. Ann Oncol. 2015. PMID: 26117829 Free PMC article.

2

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.

Paller CJ, Antonarakis ES. Paller CJ, et al. Drug Des Devel Ther. 2011 Mar 10;5:117-24. doi: 10.2147/DDDT.S13029. Drug Des Devel Ther. 2011. PMID: 21448449 Free PMC article. Review.

3

Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challenges.

Paller CJ, Antonarakis ES. Paller CJ, et al. Hum Vaccin Immunother. 2012 Apr;8(4):509-19. doi: 10.4161/hv.18860. Epub 2012 Apr 1. Hum Vaccin Immunother. 2012. PMID: 22336881 Review.

4

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.

Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH, Stockton BR, Hertzman BL, Efros MD, Roper RP, Liker HR, Carducci MA. Paller CJ, et al. Prostate Cancer Prostatic Dis. 2013 Mar;16(1):50-5. doi: 10.1038/pcan.2012.20. Epub 2012 Jun 12. Prostate Cancer Prostatic Dis. 2013. PMID: 22689129 Free PMC article. Clinical Trial.

5

Management of bone metastases in refractory prostate cancer--role of denosumab.

Paller CJ, Carducci MA, Philips GK. Paller CJ, et al. Clin Interv Aging. 2012;7:363-72. doi: 10.2147/CIA.S27930. Epub 2012 Sep 17. Clin Interv Aging. 2012. PMID: 23049248 Free PMC article. Review.

6

Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.

Paller CJ, Antonarakis ES. Paller CJ, et al. Clin Adv Hematol Oncol. 2013 Jan;11(1):14-23. Clin Adv Hematol Oncol. 2013. PMID: 23416859 Free PMC article. Review.

7

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.

Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. Paller CJ, et al. Prostate Cancer Prostatic Dis. 2014 Mar;17(1):28-33. doi: 10.1038/pcan.2013.40. Epub 2013 Oct 8. Prostate Cancer Prostatic Dis. 2014. PMID: 24100642 Free PMC article.

8

Management of patients with biochemical recurrence after local therapy for prostate cancer.

Paller CJ, Antonarakis ES, Eisenberger MA, Carducci MA. Paller CJ, et al. Hematol Oncol Clin North Am. 2013 Dec;27(6):1205-19, viii. doi: 10.1016/j.hoc.2013.08.005. Epub 2013 Sep 18. Hematol Oncol Clin North Am. 2013. PMID: 24188259 Free PMC article. Review.

9

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.

Paller CJ, Wissing MD, Mendonca J, Sharma A, Kim E, Kim HS, Kortenhorst MS, Gerber S, Rosen M, Shaikh F, Zahurak ML, Rudek MA, Hammers H, Rudin CM, Carducci MA, Kachhap SK. Paller CJ, et al. Cancer Med. 2014 Oct;3(5):1322-35. doi: 10.1002/cam4.289. Epub 2014 Jul 3. Cancer Med. 2014. PMID: 24989836 Free PMC article.

10

Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.

Nadal R, Zhang Z, Rahman H, Schweizer MT, Denmeade SR, Paller CJ, Carducci MA, Eisenberger MA, Antonarakis ES. Nadal R, et al. Among authors: paller cj. Prostate. 2014 Nov;74(15):1560-8. doi: 10.1002/pros.22874. Epub 2014 Aug 31. Prostate. 2014. PMID: 25176007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page